🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04220047
Recruiting Not applicable

Effects of Left Atrial Appendage Resection and Marshall Ligament Amputation on Clinical Outcome in Patients Undergoing Off-pump Coronary Artery Bypass

NCT04220047 · tracked via the Priya Life Science China tracker
Sponsor
China National Center for Cardiovascular Diseases
Phase
Not applicable
Started
2020-04-30
Last updated
2021-01-20

Condition(s) studied

Coronary Artery DiseaseStrokeAtrial Fibrillation

Investigational drug(s) / intervention(s)

Left Atrial Appendage Resection and Marshall Ligament Amputation

Left Atrial Appendage Resection and Marshall Ligament Amputation: Left Atrial Appendage Resection and Marshall Ligament Amputation during the cardiac surgery

Study summary

Surgical occlusion of the left atrial appendage (LAAO) is sometimes performed during the cardiac surgery to reduce long-term risk of stroke.A previous study found that LAAO may be associated with increased risk of postoperative atrial fibrillation.New-onset atrial fibrillation (NOAF) after coronary artery bypass graft is related to an increased short-term and long term risk of stroke and mortality.Marshall ligament amputation may reduce the occurence of atrial fibrillation. However, little is known whether this approach is justified during the coronary artery bypass graft.Therefore, this study aimed to investigate whether LAAO and Marshall ligament amputation during off-pump coronary artery bypass was associated with reduced risks of postoperative new-onset atrial fibrillation and stroke.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * isolated first off-pump coronary artery bypass Exclusion Criteria: * Preoperative atrial fibrillation or a history of atrial fibrillation; * Concurrent cardiac or non-cardiac surgery * Intraoperative convert to bypass bypass surgery * Emergency surgery * History of previous cardiac surgery * Severe organ dysfunction

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Fuwai Hospital Beijing China Recruiting

More China National Center for Cardiovascular Diseases trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04220047 on ClinicalTrials.gov ↗ ← All trials in China